Your browser doesn't support javascript.
loading
Source-based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome.
Ge, Ruiyang; Ching, Christopher R K; Bassett, Anne S; Kushan, Leila; Antshel, Kevin M; van Amelsvoort, Therese; Bakker, Geor; Butcher, Nancy J; Campbell, Linda E; Chow, Eva W C; Craig, Michael; Crossley, Nicolas A; Cunningham, Adam; Daly, Eileen; Doherty, Joanne L; Durdle, Courtney A; Emanuel, Beverly S; Fiksinski, Ania; Forsyth, Jennifer K; Fremont, Wanda; Goodrich-Hunsaker, Naomi J; Gudbrandsen, Maria; Gur, Raquel E; Jalbrzikowski, Maria; Kates, Wendy R; Lin, Amy; Linden, David E J; McCabe, Kathryn L; McDonald-McGinn, Donna; Moss, Hayley; Murphy, Declan G; Murphy, Kieran C; Owen, Michael J; Villalon-Reina, Julio E; Repetto, Gabriela M; Roalf, David R; Ruparel, Kosha; Schmitt, J Eric; Schuite-Koops, Sanne; Angkustsiri, Kathleen; Sun, Daqiang; Vajdi, Ariana; van den Bree, Marianne; Vorstman, Jacob; Thompson, Paul M; Vila-Rodriguez, Fidel; Bearden, Carrie E.
Afiliação
  • Ge R; Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ching CRK; Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bassett AS; Imaging Genetics Center, University of Southern California, Los Angeles, California, USA.
  • Kushan L; Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Antshel KM; The Dalglish Family 22q Clinic, Department of Psychiatry and Division of Cardiology, Department of Medicine, and Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
  • van Amelsvoort T; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Bakker G; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Butcher NJ; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California, USA.
  • Campbell LE; Department of Psychology, Syracuse University, Syracuse, New York, USA.
  • Chow EWC; Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands.
  • Craig M; Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands.
  • Crossley NA; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Cunningham A; Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Daly E; School of Psychology, University of Newcastle, Callaghan, Australia.
  • Doherty JL; Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Durdle CA; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Emanuel BS; Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Fiksinski A; National Autism Unit, Bethlem Royal Hospital, Beckenham, UK.
  • Forsyth JK; Department of Psychiatry, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Fremont W; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Goodrich-Hunsaker NJ; Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Gudbrandsen M; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Gur RE; Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, UK.
  • Jalbrzikowski M; Department of Pediatrics, UC Davis MIND Institute, Davis, California, USA.
  • Kates WR; Department of Psychological and Brain Sciences, UC Santa Barbara, Santa Barbara, California, USA.
  • Lin A; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Linden DEJ; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • McCabe KL; Department of Psychology and Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.
  • McDonald-McGinn D; Department of Psychiatry and Neuropsychology, Division of Mental Health, MHeNS, Maastricht University, Maastricht, Netherlands.
  • Moss H; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California, USA.
  • Murphy DG; Department of Psychology, University of Washington, Seattle, Washington, USA.
  • Murphy KC; Department of Psychiatry and Behavioral Sciences State University of New York, Upstate Medical University Syracuse, New York, USA.
  • Owen MJ; Department of Pediatrics, UC Davis MIND Institute, Davis, California, USA.
  • Villalon-Reina JE; Department of Neurology, University of Utah, Salt Lake City, Utah, USA.
  • Repetto GM; Sackler Institute for Translational Neurodevelopment and Department of Forensic and Neurodevelopmental Sciences, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Roalf DR; Centre for Research in Psychological Wellbeing (CREW), School of Psychology, University of Roehampton, London, UK.
  • Ruparel K; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Schmitt JE; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
  • Schuite-Koops S; Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Angkustsiri K; Department of Psychiatry and Behavioral Sciences State University of New York, Upstate Medical University Syracuse, New York, USA.
  • Sun D; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California, USA.
  • Vajdi A; Graduate Interdepartmental Program in Neuroscience, UCLA School of Medicine, Los Angeles, California, USA.
  • van den Bree M; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
  • Vorstman J; School of Psychology, University of Newcastle, Callaghan, Australia.
  • Thompson PM; Department of Pediatrics, UC Davis MIND Institute, Davis, California, USA.
  • Vila-Rodriguez F; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Bearden CE; 22q and You Center, Clinical Genetics Center, and Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hum Brain Mapp ; 45(1): e26553, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38224541
ABSTRACT
22q11.2 deletion syndrome (22q11DS) is the most frequently occurring microdeletion in humans. It is associated with a significant impact on brain structure, including prominent reductions in gray matter volume (GMV), and neuropsychiatric manifestations, including cognitive impairment and psychosis. It is unclear whether GMV alterations in 22q11DS occur according to distinct structural patterns. Then, 783 participants (470 with 22q11DS 51% females, mean age [SD] 18.2 [9.2]; and 313 typically developing [TD] controls 46% females, mean age 18.0 [8.6]) from 13 datasets were included in the present study. We segmented structural T1-weighted brain MRI scans and extracted GMV images, which were then utilized in a novel source-based morphometry (SBM) pipeline (SS-Detect) to generate structural brain patterns (SBPs) that capture co-varying GMV. We investigated the impact of the 22q11.2 deletion, deletion size, intelligence quotient, and psychosis on the SBPs. Seventeen GMV-SBPs were derived, which provided spatial patterns of GMV covariance associated with a quantitative metric (i.e., loading score) for analysis. Patterns of topographically widespread differences in GMV covariance, including the cerebellum, discriminated individuals with 22q11DS from healthy controls. The spatial extents of the SBPs that revealed disparities between individuals with 22q11DS and controls were consistent with the findings of the univariate voxel-based morphometry analysis. Larger deletion size was associated with significantly lower GMV in frontal and occipital SBPs; however, history of psychosis did not show a strong relationship with these covariance patterns. 22q11DS is associated with distinct structural abnormalities captured by topographical GMV covariance patterns that include the cerebellum. Findings indicate that structural anomalies in 22q11DS manifest in a nonrandom manner and in distinct covarying anatomical patterns, rather than a diffuse global process. These SBP abnormalities converge with previously reported cortical surface area abnormalities, suggesting disturbances of early neurodevelopment as the most likely underlying mechanism.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Síndrome de DiGeorge Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Hum Brain Mapp Assunto da revista: CEREBRO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Síndrome de DiGeorge Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Hum Brain Mapp Assunto da revista: CEREBRO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá